Boston Scientific Recalls Stents http://www.thestreet.com/_yahoo/stocks/biotech/10169165.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAShares in Boston Scientific (BSX :NYSE - commentary - research) fell Friday as the company said it was recalling about 200 of its Taxus drug-coated stents. The Natick, Mass.-based company said it made the move because of characteristics in the delivery catheters that have the potential to impede balloon deflation during a coronary angioplasty procedure ... which can result in significant patient complications, including coronary artery bypass graft surgery and death." The company said it had informed the Food and Drug Administration, which has received reports of one death and 16 serious injuries associated with balloon deflation. A stent is a tiny device inserted into arteries to improve blood flow and reduce the risk of heart disease and heart attack....In its statement, the company emphasized that "the recall does not affect patients who have already received a Taxus stent, because the difficulty is with the delivery system and occurs at the time of insertion, not afterward."
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morning